Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Cetuximab + Gemox in Biliary Tract Cancer

This study has been completed.
Sponsor:
Information provided by:
Association of Research on the Biology of Liver Tumors
ClinicalTrials.gov Identifier:
NCT01216345
First received: October 4, 2010
Last updated: October 6, 2010
Last verified: October 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2009
  Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)
Publications:
Gruenberger B, Schueller J, et al: K-ras status and response in patients with advanced or metastatic cholangiocarcinoma treated with cetuximab plus gemcitabine-oxaliplatin (GEMOX): a single center phase II study J Clin Oncol 27:15s, 2009 (suppl; abstr 4586)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):